Mondrian Investment Partners LTD Has $62 Million Position in MAXIMUS, Inc. (MMS)

Mondrian Investment Partners LTD reduced its stake in MAXIMUS, Inc. (NYSE:MMS) by 2.0% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 873,465 shares of the health services provider’s stock after selling 17,954 shares during the quarter. MAXIMUS comprises 2.0% of Mondrian Investment Partners LTD’s holdings, making the stock its 19th largest holding. Mondrian Investment Partners LTD owned about 1.37% of MAXIMUS worth $61,999,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors also recently bought and sold shares of the company. Oregon Public Employees Retirement Fund increased its holdings in MAXIMUS by 6,329.9% in the fourth quarter. Oregon Public Employees Retirement Fund now owns 1,656,085 shares of the health services provider’s stock worth $25,000 after purchasing an additional 1,630,329 shares in the last quarter. Norges Bank bought a new stake in shares of MAXIMUS during the fourth quarter valued at approximately $49,088,000. Mackenzie Financial Corp increased its holdings in shares of MAXIMUS by 17.6% during the fourth quarter. Mackenzie Financial Corp now owns 1,853,213 shares of the health services provider’s stock valued at $120,626,000 after acquiring an additional 277,775 shares in the last quarter. Ranger Investment Management L.P. increased its holdings in shares of MAXIMUS by 113.2% during the fourth quarter. Ranger Investment Management L.P. now owns 467,032 shares of the health services provider’s stock valued at $30,399,000 after acquiring an additional 248,002 shares in the last quarter. Finally, Renaissance Technologies LLC increased its holdings in shares of MAXIMUS by 117.0% during the third quarter. Renaissance Technologies LLC now owns 403,700 shares of the health services provider’s stock valued at $26,265,000 after acquiring an additional 217,700 shares in the last quarter. 95.94% of the stock is currently owned by institutional investors.

Several equities research analysts recently issued reports on the company. Zacks Investment Research downgraded MAXIMUS from a “buy” rating to a “sell” rating in a report on Friday, April 12th. ValuEngine downgraded MAXIMUS from a “buy” rating to a “hold” rating in a report on Thursday, February 28th.

In other news, Director Paul R. Lederer sold 6,715 shares of the stock in a transaction dated Wednesday, February 13th. The stock was sold at an average price of $70.04, for a total transaction of $470,318.60. Following the transaction, the director now directly owns 59,029 shares in the company, valued at approximately $4,134,391.16. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Vice Chairman Richard A. Montoni sold 35,000 shares of the stock in a transaction dated Thursday, March 14th. The shares were sold at an average price of $70.97, for a total value of $2,483,950.00. Following the sale, the insider now owns 412,874 shares of the company’s stock, valued at $29,301,667.78. The disclosure for this sale can be found here. Insiders have sold a total of 54,715 shares of company stock worth $3,873,949 over the last quarter. Corporate insiders own 2.20% of the company’s stock.

Shares of NYSE MMS opened at $72.30 on Friday. The stock has a market capitalization of $4.71 billion, a price-to-earnings ratio of 21.26, a price-to-earnings-growth ratio of 2.02 and a beta of 0.96. The company has a debt-to-equity ratio of 0.11, a quick ratio of 2.32 and a current ratio of 2.32. MAXIMUS, Inc. has a twelve month low of $60.00 and a twelve month high of $74.18.

MAXIMUS (NYSE:MMS) last announced its earnings results on Thursday, May 9th. The health services provider reported $0.96 earnings per share for the quarter, topping analysts’ consensus estimates of $0.91 by $0.05. The business had revenue of $736.50 million for the quarter, compared to analyst estimates of $757.29 million. MAXIMUS had a return on equity of 20.09% and a net margin of 8.94%. The company’s quarterly revenue was up 20.2% compared to the same quarter last year. During the same period in the prior year, the company earned $0.84 EPS. Research analysts forecast that MAXIMUS, Inc. will post 3.66 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 31st. Stockholders of record on Wednesday, May 15th will be given a dividend of $0.25 per share. The ex-dividend date of this dividend is Tuesday, May 14th. This represents a $1.00 annualized dividend and a dividend yield of 1.38%. MAXIMUS’s dividend payout ratio (DPR) is presently 29.41%.

WARNING: This report was first published by Baseball Daily News and is the sole property of of Baseball Daily News. If you are viewing this report on another domain, it was stolen and reposted in violation of US & international trademark and copyright law. The original version of this report can be accessed at https://www.baseballdailydigest.com/news/2019/05/10/mondrian-investment-partners-ltd-reduces-position-in-maximus-inc-mms.html.

MAXIMUS Profile

MAXIMUS, Inc provides business process services (BPS) to government health and human services programs worldwide. The company's Health Services segment offers various BPS, appeals, and assessments for state, provincial, and national government programs, including Medicaid, Children's Health Insurance Program, Affordable Care Act, Health Insurance British Columbia, Health Assessment Advisory Service contract, and Preadmission Screening and Resident Reviews.

Recommended Story: The basics of gap trading strategies

Institutional Ownership by Quarter for MAXIMUS (NYSE:MMS)

Receive News & Ratings for MAXIMUS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS and related companies with MarketBeat.com's FREE daily email newsletter.